High-throughput phase-distribution method to determine drug-cyclodextrin binding constants
Article first published online: 21 APR 2008
DOI: 10.1002/jps.21396
Copyright © 2008 Wiley-Liss, Inc.
Total views since August 2010: 104
Additional Information
How to Cite
Chen, Z., Lu, D. and Weber, S. G. (2009), High-throughput phase-distribution method to determine drug-cyclodextrin binding constants. J. Pharm. Sci., 98: 229–238. doi: 10.1002/jps.21396
Publication History
- Issue published online: 24 NOV 2008
- Article first published online: 21 APR 2008
- Manuscript Accepted: 27 FEB 2008
- Manuscript Revised: 4 FEB 2008
- Manuscript Received: 21 NOV 2007
Keywords:
- cyclodextrin;
- complexation;
- binding constant;
- high throughput technologies;
- solubility;
- distribution
Abstract
A high-throughput method has been developed to measure drug-cyclodextrin binding constants. It measures the distribution ratio of a drug between a polymer film [polyvinyl chloride (PVC) with 67% (w/w) dioctyl sebacate (DOS)] and a cyclodextrin-containing buffer in a 96-well format. Measurements of distribution ratios at several cyclodextrin concentrations lead to binding constants. Binding constants for econazole with six CDs have been determined in one 96-well microplate with four replications of each condition in 10 h. The K1:1/103 M−1 values are 3.98 ± 0.13, 3.90 ± 0.22, 29.3 ± 2.2, 0.66 ± 0.04, 1.78 ± 0.30, 4.08 ± 0.50, with (2-hydroxyethyl)-β-cyclodextrin, (2-hydroxypropyl)-β-cyclodextrin, 2,6-di-O-methyl-β-cyclodextrin, heptakis(2,3,6-tri-O-methyl)-β-cyclodextrin, α-cyclodextrin, β-cyclodextrin, respectively. It is likely that 1:2 complexes are also formed in some cases. This method has also been applied to study the binding behavior as a function of the drug concentration and pH. Binding weakens at higher drug concentration which may be due to the self-association of the drug. An acidic environment decreases the binding constant of CD with the basic econazole. The formation of the 1:2 complexes is completely suppressed in acid as well. This protocol is faster than the phase-solubility method. Moreover, the material requirement is up to four orders of magnitude lower. © 2008 Wiley-Liss, Inc. and the American Pharmacists Association J Pharm Sci 98:229–238, 2009

1520-6017/asset/JPS_left.gif?v=1&s=becd26fac43b87042ad04af68bbe20d6a12e64fc)
1520-6017/asset/olbannerright.jpg?v=1&s=254f44b422de0f476861bd1056a1789033e2171c)
1520-6017/asset/cover.gif?v=1&s=e589ccf35fd012c675e943835781318cb8666bed)